Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Prestige Consumer Healthcare (PBH) Cash from Financing Activities: 2009-2025

Historic Cash from Financing Activities for Prestige Consumer Healthcare (PBH) over the last 16 years, with Sep 2025 value amounting to -$74.9 million.

  • Prestige Consumer Healthcare's Cash from Financing Activities fell 46.38% to -$74.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$176.6 million, marking a year-over-year increase of 29.37%. This contributed to the annual value of -$182.1 million for FY2025, which is 24.45% up from last year.
  • According to the latest figures from Q3 2025, Prestige Consumer Healthcare's Cash from Financing Activities is -$74.9 million, which was down 106.57% from -$36.3 million recorded in Q2 2025.
  • Over the past 5 years, Prestige Consumer Healthcare's Cash from Financing Activities peaked at $63.6 million during Q2 2021, and registered a low of -$83.7 million during Q1 2021.
  • In the last 3 years, Prestige Consumer Healthcare's Cash from Financing Activities had a median value of -$54.2 million in 2023 and averaged -$55.9 million.
  • Data for Prestige Consumer Healthcare's Cash from Financing Activities shows a peak YoY increase of 167.11% (in 2021) and a maximum YoY decrease of 647.88% (in 2021) over the last 5 years.
  • Quarterly analysis of 5 years shows Prestige Consumer Healthcare's Cash from Financing Activities stood at -$67.6 million in 2021, then spiked by 85.18% to -$10.0 million in 2022, then slumped by 547.07% to -$64.8 million in 2023, then increased by 16.93% to -$53.9 million in 2024, then crashed by 46.38% to -$74.9 million in 2025.
  • Its last three reported values are -$74.9 million in Q3 2025, -$36.3 million for Q2 2025, and -$11.5 million during Q1 2025.